Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ATM |
| Variant | R3008H |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | ATM R3008H does not lie within any known functional domains of the Atm protein (UniProt.org). R3008H demonstrates kinase activity in an in vitro assay and recruitment to DNA damage sites similar to wild-type Atm protein, but results in decreased Atm activation, altered irradiation-induced cell cycle checkpoint, partial loss of tumor suppressor function (PMID: 33239428), and failure to induce Tp53 target gene expression after DNA damage in patient-derived cells (PMID: 23585524), and therefore, is predicted to lead to a loss of Atm protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ATM mutant ATM inact mut ATM R3008H ATM mutant ATM R3008X ATM R3008H |
| Transcript | NM_000051.4 |
| gDNA | chr11:g.108365360G>A |
| cDNA | c.9023G>A |
| Protein | p.R3008H |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011542840.4 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_006718843.5 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_017017789.2 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_017017789 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_005271562 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_006718843.4 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_047426976.1 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_011542840 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_047426975.1 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_017017790 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_006718843 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_011542840.3 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_017017790.3 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| NM_000051.4 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_005271561 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_017017790.2 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| NM_000051 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| NM_000051.3 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| NM_001351834.2 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| NM_001351834.1 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_005271562.5 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| XM_005271562.6 | chr11:g.108365360G>A | c.9023G>A | p.R3008H | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|